Tag: News
Latest article
Regeneron’s Eylea lowers vision-threatening occasions in diabetes trial
Regeneron Pharmaceuticals has reported initial...
Healio: DARE-19: Dapagliflozin well-tolerated for inpatient COVID-19 with, with out diabetes
The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...
Prediabetes may influence long-term mind well being
Researchers have...